Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 12,375 shares at $50.00 ($600K) on 2015-03-05, disclosed to the SEC on 2015-03-05.
Scheduled sale ($600k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.99 | 6,190 | $291K | 48.5% |
| 2 | $50.00 | 6,185 | $309K | 51.5% |
| Total | $48.49 avg | 12,375 | $600K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |
| KYTH | SELL | 2015-02-19 | $32K | — | Filing → |